Descriptions

The autoinhibited protein was predicted that may have potential autoinhibitory elements via cis-regPred.

Autoinhibitory domains (AIDs)

Target domain

Relief mechanism

Assay

cis-regPred

Accessory elements

172-198 (Activation loop from InterPro)

Target domain

21-335 (Protein kinase domain)

Relief mechanism

Assay

Autoinhibited structure

Activated structure

1 structures for Q9BWU1

Entry ID Method Resolution Chain Position Source
AF-Q9BWU1-F1 Predicted AlphaFoldDB

225 variants for Q9BWU1

Variant ID(s) Position Change Description Diseaes Association Provenance
rs1783518890
RCV001250468
VAR_084392
28 G>A DEE87 [UniProt] Yes ClinVar
UniProt
dbSNP
RCV001252679
RCV001250465
rs1783519120
VAR_084393
RCV001252678
28 G>R Developmental and epileptic encephalopathy, 87 DEE87; decreased protein kinase activity [ClinVar, UniProt] Yes ClinVar
dbSNP
UniProt
rs1783518295
RCV001250507
31 T>N Developmental and epileptic encephalopathy, 87 [ClinVar] Yes ClinVar
dbSNP
rs1783517622
RCV001252680
VAR_084394
32 Y>C Developmental and epileptic encephalopathy, 87 DEE87 [ClinVar, UniProt] Yes ClinVar
UniProt
dbSNP
RCV001195090
rs1236246272
CA365245579
VAR_084395
32 Y>H Developmental and epileptic encephalopathy, 87 DEE87; fails to rescue neurologic phenotypes in a Drosophila model system; increased protein kinase activity [ClinVar, UniProt] Yes ClinGen
ClinVar
UniProt
dbSNP
gnomAD
rs1779473650
RCV001255605
RCV002560185
TCGA novel
RCV001195089
VAR_084396
196 T>A Developmental and epileptic encephalopathy, 87 Variant assessed as Somatic; impact. Inborn genetic diseases DEE87; fails to rescue neurologic phenotypes in a Drosophila model system [ClinVar, NCI-TCGA, UniProt] Yes ClinVar
NCI-TCGA
UniProt
dbSNP
rs1779473436
VAR_084397
RCV001252681
197 F>L Developmental and epileptic encephalopathy, 87 DEE87 [ClinVar, UniProt] Yes ClinVar
UniProt
dbSNP
rs1779473213
VAR_084398
RCV001252682
198 W>C Developmental and epileptic encephalopathy, 87 DEE87 [ClinVar, UniProt] Yes ClinVar
UniProt
dbSNP
VAR_084399
rs1779472995
RCV001250464
200 R>W DEE87 [UniProt] Yes ClinVar
UniProt
dbSNP
RCV001252732
CA3958895
rs55914301
COSM39303
395 A>V central_nervous_system Microcephaly [Cosmic, ClinVar] Yes ClinGen
cosmic curated
ClinVar
1000Genomes
ExAC
TOPMed
dbSNP
gnomAD
TCGA novel 3 Y>F Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA365245767
rs1404396903
4 D>G No ClinGen
gnomAD
CA365245727
rs1562311725
10 A>T No ClinGen
Ensembl
rs757584020
CA3959241
12 E>Q No ClinGen
ExAC
gnomAD
rs145535321
CA145220410
13 R>W No ClinGen
ESP
TOPMed
gnomAD
rs1156998824
CA365245705
14 E>K No ClinGen
gnomAD
rs760961719
CA3959238
18 D>E No ClinGen
ExAC
gnomAD
CA3959239
rs764169323
18 D>N No ClinGen
ExAC
gnomAD
CA365245599
rs1483542851
29 R>S No ClinGen
gnomAD
rs1324013746
CA365245550
36 Y>C No ClinGen
TOPMed
CA365245541
rs1241915940
37 K>R No ClinGen
gnomAD
CA3959234
rs773263211
40 R>G Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
ExAC
NCI-TCGA
gnomAD
rs773263211
CA365245524
40 R>W No ClinGen
ExAC
gnomAD
rs761477193
CA3959232
43 G>R No ClinGen
ExAC
TOPMed
gnomAD
TCGA novel 44 K>Q Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs1462361150
CA365355594
45 D>E No ClinGen
TOPMed
rs1385019803
CA365355600
45 D>N No ClinGen
gnomAD
CA365355597
rs1290014343
45 D>V No ClinGen
gnomAD
CA3959168
rs762489169
48 E>K No ClinGen
ExAC
gnomAD
TCGA novel 57 T>A Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA3959165
rs748670469
59 I>L No ClinGen
ExAC
TOPMed
gnomAD
CA365355499
rs748670469
59 I>V No ClinGen
ExAC
TOPMed
gnomAD
rs777345140
CA3959164
60 S>A No ClinGen
ExAC
rs1487705565
CA365355410
65 R>T No ClinGen
gnomAD
CA3959120
rs759991863
71 R>* No ClinGen
ExAC
gnomAD
CA365354321
rs1297296367
77 N>T No ClinGen
TOPMed
TCGA novel 78 V>A Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs1229122867
CA365354287
82 Q>R No ClinGen
gnomAD
CA365354279
rs1334230328
83 K>R No ClinGen
gnomAD
CA365354247
COSM1634423
rs1582824930
88 H>Y liver [Cosmic] No ClinGen
cosmic curated
Ensembl
CA3959112
rs758096037
96 L>V No ClinGen
ExAC
gnomAD
rs750261087
CA3959111
100 A>S No ClinGen
ExAC
gnomAD
rs1219070923
CA365354057
COSM201168
112 R>C Variant assessed as Somatic; 0.0 impact. large_intestine [NCI-TCGA, Cosmic] No ClinGen
cosmic curated
NCI-TCGA
gnomAD
TCGA novel 113 A>T Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA365354024
rs1426767970
117 N>S No ClinGen
gnomAD
CA365353994
rs1317130024
121 M>R No ClinGen
TOPMed
rs1275907568
CA365353996
121 M>V Variant assessed as Somatic; impact. [NCI-TCGA] No ClinGen
NCI-TCGA
TOPMed
rs1233609881
CA365353981
122 Q>H No ClinGen
TOPMed
CA145825554
rs980853034
124 P>S No ClinGen
gnomAD
CA365353973
rs980853034
124 P>T No ClinGen
gnomAD
CA365353968
rs1290455860
125 R>G No ClinGen
gnomAD
CA145825553
rs554919650
127 M>T No ClinGen
Ensembl
rs748931875
CA3959084
128 V>G No ClinGen
ExAC
TOPMed
gnomAD
CA145825552
rs200697462
128 V>I No ClinGen
1000Genomes
ExAC
TOPMed
gnomAD
CA3959085
rs200697462
128 V>L No ClinGen
1000Genomes
ExAC
TOPMed
gnomAD
rs1209146999
CA365353921
132 L>F No ClinGen
TOPMed
rs1259552312
CA365353861
140 H>Q No ClinGen
gnomAD
CA3959081
rs752285573
143 H>L No ClinGen
ExAC
gnomAD
TCGA novel 145 N>Q Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
TCGA novel 152 L>= Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs758734214
CA3959059
160 M>K No ClinGen
ExAC
TOPMed
gnomAD
rs758734214
CA3959060
160 M>T No ClinGen
ExAC
TOPMed
gnomAD
CA3959058
rs750806739
161 G>R No ClinGen
ExAC
gnomAD
rs765317905
CA3959057
165 E>D No ClinGen
ExAC
gnomAD
rs762098741
CA3959056
168 R>S No ClinGen
ExAC
gnomAD
CA365357695
rs1214040281
169 V>D No ClinGen
gnomAD
TCGA novel 176 F>L Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA365357602
rs1386634373
181 N>H No ClinGen
TOPMed
CA365357598
rs1562139375
181 N>S No ClinGen
Ensembl
TCGA novel 182 S>Y Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs1325061809
CA365357583
183 P>L No ClinGen
gnomAD
TCGA novel 183 P>missing Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs1562139316
CA365357518
193 V>G No ClinGen
Ensembl
TCGA novel 202 P>L Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA145821935
rs940533589
203 E>K No ClinGen
Ensembl
CA365357421
rs1193696403
208 A>G No ClinGen
gnomAD
CA365357417
rs1373241481
209 R>K No ClinGen
gnomAD
CA145821431
rs916860957
218 W>* No ClinGen
TOPMed
rs1055319082
CA145821430
228 L>V No ClinGen
TOPMed
gnomAD
rs953895657
COSM174895
CA145821429
230 S>L Variant assessed as Somatic; 0.0 impact. large_intestine [NCI-TCGA, Cosmic] No ClinGen
cosmic curated
NCI-TCGA
TOPMed
gnomAD
TCGA novel 235 H>S Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA3959018
rs749643967
237 R>H No ClinGen
ExAC
gnomAD
rs756420255
CA3959016
241 I>T No ClinGen
ExAC
TOPMed
gnomAD
CA145821428
rs780608956
241 I>V No ClinGen
Ensembl
CA365357150
rs1275224408
245 N>Y No ClinGen
gnomAD
CA145821426
rs368779010
249 H>N No ClinGen
ExAC
gnomAD
rs368779010
CA3959015
249 H>Y No ClinGen
ExAC
gnomAD
rs1349823433
CA365357087
COSM260037
254 R>W Variant assessed as Somatic; 0.0 impact. large_intestine [NCI-TCGA, Cosmic] No ClinGen
cosmic curated
NCI-TCGA
gnomAD
CA365357039
rs1306900740
260 G>E No ClinGen
gnomAD
rs865823701
CA145821424
263 A>V No ClinGen
Ensembl
CA145821414
rs1055234651
264 D>G No ClinGen
Ensembl
TCGA novel 271 R>S Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs865965891
CA145821413
273 M>K No ClinGen
Ensembl
CA3958991
rs751624560
273 M>V No ClinGen
ExAC
gnomAD
TCGA novel 277 P>H Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs1410735559
CA365356908
277 P>T No ClinGen
gnomAD
rs187493296
CA3958989
287 T>A No ClinGen
1000Genomes
ExAC
rs753876969
CA3958988
287 T>M No ClinGen
ExAC
gnomAD
rs1273781226
CA365356797
291 S>N No ClinGen
gnomAD
CA3958968
rs753749481
294 I>M No ClinGen
ExAC
gnomAD
rs200880669
CA3958969
294 I>V No ClinGen
1000Genomes
ExAC
TOPMed
gnomAD
rs1373271422
CA365356755
297 M>K No ClinGen
TOPMed
rs777727767
CA3958967
297 M>L No ClinGen
ExAC
gnomAD
rs1363705470
CA365356731
300 H>Y No ClinGen
gnomAD
rs767097773
CA3958964
301 K>N No ClinGen
ExAC
gnomAD
TCGA novel 304 P>S Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs1433795864
CA365356633
312 L>F No ClinGen
gnomAD
CA3958945
rs754862400
314 K>R No ClinGen
ExAC
TOPMed
gnomAD
CA365356599
rs762517170
317 T>I No ClinGen
ExAC
gnomAD
rs762517170
CA3958942
317 T>S No ClinGen
ExAC
gnomAD
CA145821012
rs921734283
324 I>N No ClinGen
TOPMed
CA365356540
rs1481343583
326 S>A No ClinGen
gnomAD
rs975083127
CA145821011
326 S>L No ClinGen
TOPMed
rs761138528
CA3958937
333 P>A No ClinGen
ExAC
gnomAD
CA365356493
rs1280052591
333 P>H No ClinGen
TOPMed
rs761138528
CA3958936
333 P>S Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
ExAC
NCI-TCGA
gnomAD
rs1282897871
CA365356486
334 Y>C No ClinGen
gnomAD
TCGA novel 334 Y>H Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA365356471
rs1237424581
336 Q>R No ClinGen
gnomAD
CA365356458
rs1316813423
338 D>N No ClinGen
gnomAD
rs1353016152
CA365356449
339 P>A No ClinGen
TOPMed
rs1244482015
CA365356380
347 A>V No ClinGen
TOPMed
CA3958917
rs760899404
348 G>S Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
ExAC
NCI-TCGA
TOPMed
gnomAD
rs1293726339
CA365356355
351 I>V No ClinGen
gnomAD
CA365356329
rs1380275260
354 P>L No ClinGen
gnomAD
CA365356327
rs1383983955
355 K>E No ClinGen
gnomAD
CA365356319
rs1289319819
356 R>* No ClinGen
gnomAD
rs1239138510
CA365356316
356 R>Q No ClinGen
TOPMed
CA365356301
rs1455274232
358 F>L No ClinGen
gnomAD
TCGA novel 359 L>I Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs1261907348
CA365356281
361 E>G No ClinGen
TOPMed
CA365356261
rs1392285893
364 P>T No ClinGen
gnomAD
rs375353769
CA145820967
368 G>R No ClinGen
ESP
TCGA novel 369 D>N Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs1251968288
CA365356183
372 Q>H No ClinGen
TOPMed
rs756783771
CA3958899
377 N>T No ClinGen
ExAC
TOPMed
gnomAD
rs764451268
CA3958897
379 H>Y No ClinGen
ExAC
gnomAD
TCGA novel 381 Q>* Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs1252871484
CA365356119
381 Q>E No ClinGen
gnomAD
CA365356113
rs1179651343
381 Q>H No ClinGen
TOPMed
rs1410791361
CA365356109
382 P>L No ClinGen
TOPMed
CA365356101
rs1194812139
383 T>I No ClinGen
gnomAD
rs1469838359
CA365356092
385 P>S No ClinGen
gnomAD
CA365356072
rs1248495183
388 Q>E No ClinGen
gnomAD
rs1195371419
CA365356071
388 Q>P No ClinGen
gnomAD
CA3958896
rs756647858
389 A>T No ClinGen
ExAC
gnomAD
CA365356056
rs1253352940
390 A>V No ClinGen
gnomAD
rs1174138651
CA365356027
395 A>T No ClinGen
TOPMed
CA3958893
rs759944605
396 P>L No ClinGen
ExAC
gnomAD
rs1329446147
CA365356018
397 P>A No ClinGen
TOPMed
CA145820913
rs546919397
397 P>L No ClinGen
1000Genomes
ExAC
TOPMed
gnomAD
rs546919397
CA3958892
397 P>Q No ClinGen
1000Genomes
ExAC
TOPMed
gnomAD
rs1582691168
CA365356013
398 P>S No ClinGen
Ensembl
TCGA novel 400 Q>K Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA3958891
rs766619789
402 S>C No ClinGen
ExAC
gnomAD
CA3958890
rs762896900
403 T>S No ClinGen
ExAC
gnomAD
CA365355953
rs1309504394
406 N>K No ClinGen
TOPMed
gnomAD
rs773360002
CA3958889
407 G>R No ClinGen
ExAC
gnomAD
CA365355946
rs1394872857
408 T>P No ClinGen
gnomAD
rs570611641
CA3958887
409 A>T No ClinGen
ExAC
TOPMed
gnomAD
CA365355936
rs1272012303
409 A>V No ClinGen
gnomAD
rs1362613045
CA365355932
410 G>V Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
NCI-TCGA
gnomAD
TCGA novel 411 G>V Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
TCGA novel 412 A>V Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA365355914
rs1196942838
413 G>R No ClinGen
TOPMed
rs745684988
CA3958884
415 G>R No ClinGen
ExAC
gnomAD
CA3958883
rs548129906
416 V>I No ClinGen
1000Genomes
ExAC
gnomAD
CA365355893
rs1340287712
COSM1072144
417 G>R Variant assessed as Somatic; 0.0 impact. endometrium [NCI-TCGA, Cosmic] No ClinGen
cosmic curated
NCI-TCGA
TOPMed
CA365355885
rs1562126547
418 G>S No ClinGen
Ensembl
rs1347007822
CA365355876
419 T>I No ClinGen
gnomAD
CA3958878
rs145745297
420 G>R No ClinGen
ESP
ExAC
gnomAD
rs199931376
CA3958877
COSM1072143
421 A>T Variant assessed as Somatic; 0.0 impact. endometrium [NCI-TCGA, Cosmic] No ClinGen
cosmic curated
1000Genomes
ExAC
NCI-TCGA
TOPMed
gnomAD
rs1309411704
CA365355866
421 A>V No ClinGen
TOPMed
gnomAD
rs1582690742
CA365355862
422 G>A No ClinGen
Ensembl
rs911298280
CA145820910
423 L>M No ClinGen
Ensembl
CA3958876
rs375258247
424 Q>* No ClinGen
ESP
ExAC
TOPMed
gnomAD
CA365355842
rs1374549254
425 H>R No ClinGen
gnomAD
CA3958875
rs751944182
426 S>R No ClinGen
ExAC
gnomAD
rs766533848
CA3958874
428 D>V No ClinGen
ExAC
gnomAD
CA3958873
rs531311578
429 S>C No ClinGen
1000Genomes
ExAC
gnomAD
CA3958872
rs750680904
430 S>R No ClinGen
ExAC
gnomAD
CA3958871
rs765349281
430 S>R No ClinGen
ExAC
gnomAD
rs1172697598
CA365355791
433 Q>E No ClinGen
TOPMed
gnomAD
rs761836116
CA3958870
434 V>L No ClinGen
ExAC
gnomAD
rs376573708
CA3958868
436 P>T No ClinGen
1000Genomes
ExAC
TOPMed
gnomAD
rs759343831
CA3958867
438 K>E No ClinGen
ExAC
gnomAD
CA365355744
rs1443955357
440 P>A No ClinGen
gnomAD
CA3958866
rs774291402
441 R>Q Variant assessed as Somatic; 4.623e-05 impact. [NCI-TCGA] No ClinGen
ExAC
NCI-TCGA
gnomAD
CA365355738
rs1281979042
441 R>W No ClinGen
gnomAD
CA365355719
rs1354410644
444 P>L No ClinGen
gnomAD
CA365355704
rs1450585259
447 A>S No ClinGen
TOPMed
gnomAD
CA365355706
rs1450585259
447 A>T No ClinGen
TOPMed
gnomAD
CA3958862
rs769319056
453 V>M No ClinGen
ExAC
TOPMed
gnomAD
CA3958861
rs747643636
454 M>V No ClinGen
ExAC
gnomAD
rs1228619572
CA365355653
455 P>S No ClinGen
TOPMed
rs781628403
CA3958860
456 S>L Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
ExAC
NCI-TCGA
TOPMed
gnomAD
rs1449876565
CA365354912
460 H>R No ClinGen
gnomAD
CA3958841
rs768226674
460 H>Y No ClinGen
ExAC
TOPMed
gnomAD
rs1191674190
CA365354896
461 S>P No ClinGen
gnomAD
CA365354875
rs1467593689
462 S>T No ClinGen
gnomAD
CA3958839
rs373933843
COSM1072141
464 R>C Variant assessed as Somatic; 0.0 impact. endometrium [NCI-TCGA, Cosmic] No ClinGen
cosmic curated
ESP
ExAC
NCI-TCGA
TOPMed
gnomAD
rs758747416
CA3958838
464 R>H No ClinGen
ExAC
TOPMed
gnomAD
rs1305376207
CA365354832
465 L>P No ClinGen
gnomAD
rs779134930
CA3958836
470 S>R No ClinGen
ExAC
TOPMed
gnomAD
rs764256188
CA3958834
471 V>F No ClinGen
ExAC
TOPMed
gnomAD
rs764256188
CA3958833
471 V>I Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
ExAC
NCI-TCGA
TOPMed
gnomAD
CA3958832
rs756309724
472 Q>R No ClinGen
ExAC
gnomAD
rs1471050497
CA365354684
473 G>R No ClinGen
TOPMed
CA365354642
rs1440180529
476 Q>E Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
NCI-TCGA
gnomAD
CA145820260
rs1053526679
476 Q>R No ClinGen
TOPMed
rs1281492474
CA365354582
479 S>C No ClinGen
gnomAD
rs1582669652
CA365354513
485 S>F No ClinGen
Ensembl
rs766259977
CA3958829
486 S>L No ClinGen
ExAC
gnomAD
CA365354475
rs1309316274
491 S>A No ClinGen
TOPMed
rs1582669576
CA365354452
494 H>P No ClinGen
Ensembl
CA145820257
rs868855764
495 P>L No ClinGen
Ensembl
CA145820258
rs928696407
495 P>T No ClinGen
TOPMed
gnomAD
CA365354425
rs1171590583
498 Q>R No ClinGen
gnomAD
rs1562119282
CA365354416
499 A>G No ClinGen
Ensembl
rs1326125252
CA365354421
499 A>T No ClinGen
TOPMed
rs1310668301
CA365354412
500 H>R No ClinGen
gnomAD
CA3958824
rs776325246
501 R>Q No ClinGen
ExAC
TOPMed
gnomAD
rs761454481
CA3958825
501 R>W Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
ExAC
NCI-TCGA
TOPMed
gnomAD
rs1195851303
CA365354401
502 Y>C No ClinGen
TOPMed
CA3958822
rs377400438
503 Y>R No ClinGen
ESP
ExAC
TOPMed
gnomAD

1 associated diseases with Q9BWU1

[MIM: 618916]: Developmental and epileptic encephalopathy 87 (DEE87)

A form of epileptic encephalopathy, a heterogeneous group of severe early-onset epilepsies characterized by refractory seizures, neurodevelopmental impairment, and poor prognosis. Development is normal prior to seizure onset, after which cognitive and motor delays become apparent. DEE87 inheritance is autosomal dominant. {ECO:0000269|PubMed:32330417, ECO:0000269|PubMed:33134521, ECO:0000269|PubMed:33495529}. Note=The disease is caused by variants affecting the gene represented in this entry.

Without disease ID
  • A form of epileptic encephalopathy, a heterogeneous group of severe early-onset epilepsies characterized by refractory seizures, neurodevelopmental impairment, and poor prognosis. Development is normal prior to seizure onset, after which cognitive and motor delays become apparent. DEE87 inheritance is autosomal dominant. {ECO:0000269|PubMed:32330417, ECO:0000269|PubMed:33134521, ECO:0000269|PubMed:33495529}. Note=The disease is caused by variants affecting the gene represented in this entry.

3 regional properties for Q9BWU1

Type Name Position InterPro Accession
domain Protein kinase domain 21 - 335 IPR000719
active_site Serine/threonine-protein kinase, active site 147 - 159 IPR008271
binding_site Protein kinase, ATP binding site 27 - 52 IPR017441

Functions

Description
EC Number 2.7.11.22 Protein-serine/threonine kinases
Subcellular Localization
  • Cytoplasm
  • Cytoplasm, perinuclear region
  • Nucleus
PANTHER Family
PANTHER Subfamily
PANTHER Protein Class
PANTHER Pathway Category No pathway information available

5 GO annotations of cellular component

Name Definition
cytosol The part of the cytoplasm that does not contain organelles but which does contain other particulate matter, such as protein complexes.
mediator complex A protein complex that interacts with the carboxy-terminal domain of the largest subunit of RNA polymerase II and plays an active role in transducing the signal from a transcription factor to the transcriptional machinery. The mediator complex is required for activation of transcription of most protein-coding genes, but can also act as a transcriptional corepressor. The Saccharomyces complex contains several identifiable subcomplexes: a head domain comprising Srb2, -4, and -5, Med6, -8, and -11, and Rox3 proteins; a middle domain comprising Med1, -4, and -7, Nut1 and -2, Cse2, Rgr1, Soh1, and Srb7 proteins; a tail consisting of Gal11p, Med2p, Pgd1p, and Sin4p; and a regulatory subcomplex comprising Ssn2, -3, and -8, and Srb8 proteins. Metazoan mediator complexes have similar modular structures and include homologs of yeast Srb and Med proteins.
nucleoplasm That part of the nuclear content other than the chromosomes or the nucleolus.
nucleus A membrane-bounded organelle of eukaryotic cells in which chromosomes are housed and replicated. In most cells, the nucleus contains all of the cell's chromosomes except the organellar chromosomes, and is the site of RNA synthesis and processing. In some species, or in specialized cell types, RNA metabolism or DNA replication may be absent.
perinuclear region of cytoplasm Cytoplasm situated near, or occurring around, the nucleus.

4 GO annotations of molecular function

Name Definition
ATP binding Binding to ATP, adenosine 5'-triphosphate, a universally important coenzyme and enzyme regulator.
cyclin-dependent protein serine/threonine kinase activity Cyclin-dependent catalysis of the reactions: ATP + protein serine = ADP + protein serine phosphate, and ATP + protein threonine = ADP + protein threonine phosphate.
protein serine kinase activity Catalysis of the reactions: ATP + protein serine = ADP + protein serine phosphate.
RNA polymerase II CTD heptapeptide repeat kinase activity Catalysis of the reaction: ATP + RNA polymerase II large subunit CTD heptapeptide repeat (YSPTSPS) = ADP + H+ + phosphorylated RNA polymerase II.

4 GO annotations of biological process

Name Definition
cellular response to lipopolysaccharide Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a lipopolysaccharide stimulus; lipopolysaccharide is a major component of the cell wall of gram-negative bacteria.
positive regulation of apoptotic process Any process that activates or increases the frequency, rate or extent of cell death by apoptotic process.
positive regulation of inflammatory response Any process that activates or increases the frequency, rate or extent of the inflammatory response.
protein phosphorylation The process of introducing a phosphate group on to a protein.

19 homologous proteins in AiPD

UniProt AC Gene Name Protein Name Species Evidence Code
P39073 SSN3 Meiotic mRNA stability protein kinase SSN3 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) (Baker's yeast) PR
Q9VT57 Cdk8 Cyclin-dependent kinase 8 Drosophila melanogaster (Fruit fly) PR
Q15131 CDK10 Cyclin-dependent kinase 10 Homo sapiens (Human) PR
Q9UQ88 CDK11A Cyclin-dependent kinase 11A Homo sapiens (Human) PR
Q00526 CDK3 Cyclin-dependent kinase 3 Homo sapiens (Human) PR
Q96Q40 CDK15 Cyclin-dependent kinase 15 Homo sapiens (Human) PR
O94921 CDK14 Cyclin-dependent kinase 14 Homo sapiens (Human) PR
Q00537 CDK17 Cyclin-dependent kinase 17 Homo sapiens (Human) PR
P49336 CDK8 Cyclin-dependent kinase 8 Homo sapiens (Human) PR
P50750 CDK9 Cyclin-dependent kinase 9 Homo sapiens (Human) PR
Q5MAI5 CDKL4 Cyclin-dependent kinase-like 4 Homo sapiens (Human) PR
Q00532 CDKL1 Cyclin-dependent kinase-like 1 Homo sapiens (Human) PR
Q92772 CDKL2 Cyclin-dependent kinase-like 2 Homo sapiens (Human) PR
Q8IZL9 CDK20 Cyclin-dependent kinase 20 Homo sapiens (Human) PR
P21127 CDK11B Cyclin-dependent kinase 11B Homo sapiens (Human) PR
Q8R3L8 Cdk8 Cyclin-dependent kinase 8 Mus musculus (Mouse) PR
Q8BWD8 Cdk19 Cyclin-dependent kinase 19 Mus musculus (Mouse) PR
Q6P3N6 cdk8 Cyclin-dependent kinase 8 Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) PR
Q8JH47 cdk8 Cyclin-dependent kinase 8 Danio rerio (Zebrafish) (Brachydanio rerio) PR
10 20 30 40 50 60
MDYDFKAKLA AERERVEDLF EYEGCKVGRG TYGHVYKARR KDGKDEKEYA LKQIEGTGIS
70 80 90 100 110 120
MSACREIALL RELKHPNVIA LQKVFLSHSD RKVWLLFDYA EHDLWHIIKF HRASKANKKP
130 140 150 160 170 180
MQLPRSMVKS LLYQILDGIH YLHANWVLHR DLKPANILVM GEGPERGRVK IADMGFARLF
190 200 210 220 230 240
NSPLKPLADL DPVVVTFWYR APELLLGARH YTKAIDIWAI GCIFAELLTS EPIFHCRQED
250 260 270 280 290 300
IKTSNPFHHD QLDRIFSVMG FPADKDWEDI RKMPEYPTLQ KDFRRTTYAN SSLIKYMEKH
310 320 330 340 350 360
KVKPDSKVFL LLQKLLTMDP TKRITSEQAL QDPYFQEDPL PTLDVFAGCQ IPYPKREFLN
370 380 390 400 410 420
EDDPEEKGDK NQQQQQNQHQ QPTAPPQQAA APPQAPPPQQ NSTQTNGTAG GAGAGVGGTG
430 440 450 460 470 480
AGLQHSQDSS LNQVPPNKKP RLGPSGANSG GPVMPSDYQH SSSRLNYQSS VQGSSQSQST
490 500
LGYSSSSQQS SQYHPSHQAH RY